Two Sigma Securities, LLC Biogen Inc. Call Options Transaction History

Two Sigma Securities, LLC

$8.19 Billion
Q2 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $2.82 Million - $3.5 Million	-14,800 Reduced 50.68%	14,400 $3.34 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $5.75 Million - $7.25 Million	27,100 Added 1290.48%	29,200 $6.3 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $934,878 - $1.13 Million	-4,200 Reduced 66.67%	2,100 $543,000
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $911,880 - $1.03 Million	3,600 Added 133.33%	6,300 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $192,675 - $222,642	700 Added 35.0%	2,700 $769,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $513,120 - $584,680	2,000 New	2,000 $556,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $2.98 Million - $3.55 Million	15,900 Added 265.0%	21,900 $4.47 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.16 Million - $1.46 Million	6,000 New	6,000 $1.26 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $198,093 - $258,335	-700 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $1.37 Million - $2.2 Million	-5,300 Reduced 88.33%	700 $242,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.02 Million - $1.53 Million	4,300 Added 252.94%	6,000 $1.47 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $1.56 Million - $1.8 Million	-5,900 Reduced 77.63%	1,700 $482,000
Q2 2020 Sep 10, 2020	BUY	$258.66 - $342.55 $1.6 Million - $2.12 Million	6,200 Added 442.86%	7,600 $2.03 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $3.5 Million - $4.43 Million	-13,000 Reduced 90.28%	1,400 $443,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $704,192 - $973,024	-3,200 Reduced 18.18%	14,400 $4.27 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $2.76 Million - $3.05 Million	12,600 Added 252.0%	17,600 $4.12 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $3.23 Million - $5.05 Million	-14,900 Reduced 74.87%	5,000 $1.18 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $5.65 Million - $7.16 Million	-20,300 Reduced 50.5%	19,900 $5.99 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $3.82 Million - $4.99 Million	-13,000 Reduced 24.44%	40,200 $14.2 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $3.84 Million - $4.57 Million	-14,900 Reduced 21.88%	53,200 $15.4 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $16.5 Million - $23.3 Million	63,300 Added 1318.75%	68,100 $18.6 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1.48 Million - $1.65 Million	4,800	4,800 $1.53 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account